Skip to content
naulon

Not checkedNot checked for notices yet.

New opportunities for statins during the COVID-19 pandemic

V.E. Oleynikov, I.V. Avdeeva

Известия высших учебных заведений. Поволжский регион: Медицинские науки · 2022

doi:10.21685/2072-3032-2022-3-5 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Background. Physicians around the world are faced with the fact that against the backdrop of COVID-19, there are both an exacerbation of chronic diseases existing in patients, and presentation of a new pathology associated with infection or drug treatment. One of the most common comorbid pathologies in this group of patients is cardiovascular disease. In this regard, an increased interest in statins is justified, given their lipid-lowering properties and a wide range of pleiotropic effects. Materials and methods. The article details the biochemical mechanisms of the effect of statins on inflammation based on the materials of a large number of international clinical studies. Results and conclusions. The positive effects of drugs in SARS-CoV-2 infection (influence on inflammation, in particular, “cytokine storm”, endothelial dysfunction, atherosclerotic plaque instability, myocardial hypoxia/ischemia, oxidative stress, thrombus formation) are indicated.

Abstract licence: CC BY

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.